doi	title	authors	title_name	year	downloads	visitors	countries
10.1182/asheducation-2014.1.90	Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC	S. H. Swerdlow	Hematology / the Education Program of the American Society of Hematology	2014	15	14	10
10.1182/asheducation-2014.1.158	Indolent lymphoma: follicular lymphoma and the microenvironment--insights from the microscope	N. L. Harris	Hematology / the Education Program of the American Society of Hematology	2014	16	12	5
10.1182/asheducation-2014.1.163	Indolent lymphoma: follicular lymphoma and the microenvironment--insights from gene expression profiling	L. M. Rimsza, M. C. Jaramillo	Hematology / the Education Program of the American Society of Hematology	2014	16	12	5
10.1182/blood-2014-05-577189	Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity	L. H. Sehn, R. D. Gascoyne	Blood	2014	26	12	8
10.1182/asheducation-2014.1.107	Double-hit lymphomas: current paradigms and novel treatment approaches	K. Dunleavy	Hematology / the Education Program of the American Society of Hematology	2014	11	11	8
10.1182/blood-2014-10-570234	De novo generation of HSCs from somatic and pluripotent stem cell sources	L. T. Vo, G. Q. Daley	Blood	2015	11	11	9
10.1182/blood-2014-11-575357	Emerging EPO and EPO receptor regulators and signal transducers	D. Kuhrt, D. M. Wojchowski	Blood	2015	16	11	6
10.1182/asheducation-2014.1.1	Multiple myeloma: a model for scientific and clinical progress	J. San Miguel	Hematology / the Education Program of the American Society of Hematology	2014	10	10	9
10.1182/blood-2014-12-618090	TGF-Â  signaling in the control of hematopoietic stem cells	U. Blank, S. Karlsson	Blood	2015	11	10	8
10.1182/asheducation-2014.1.393	Anticoagulation in pregnancy complications	S. Middeldorp	Hematology / the Education Program of the American Society of Hematology	2014	10	9	7
10.1182/asheducation-2014.1.536	Management of VWD	A. T. Neff, R. F. Sidonio	Hematology / the Education Program of the American Society of Hematology	2014	10	9	5
10.1182/blood-2014-12-615948	Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells	M. D. Hoban, G. J. Cost, M. C. Mendel, Z. Romero, M. L. Kaufman, A. V. Joglekar, M. Ho, D. Lumaquin, D. Gray, G. R. Lill, A. R. Cooper, F. Urbinati, S. Senadheera, A. Zhu, P.-Q. Liu, D. E. Paschon, L. Zhang, E. J. Rebar, A. Wilber, X. Wang, P. D. Gregory, M. C. Holmes, A. Reik, R. P. Hollis, D. B. Kohn	Blood	2015	11	9	4
10.1182/asheducation-2014.1.125	BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma	A. Wiestner	Hematology / the Education Program of the American Society of Hematology	2014	16	8	4
10.1182/asheducation-2014.1.14	Treating acute myeloid leukemia in older adults	E. S. Wang	Hematology / the Education Program of the American Society of Hematology	2014	9	8	5
10.1182/asheducation-2014.1.144	The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling	D. W. Scott, C. Steidl	Hematology / the Education Program of the American Society of Hematology	2014	10	8	5
10.1182/asheducation-2014.1.277	Therapy for myeloproliferative neoplasms: when, which agent, and how?	H. L. Geyer, R. A. Mesa	Hematology / the Education Program of the American Society of Hematology	2014	9	8	7
10.1182/blood-2014-09-570192	Making sense of hematopoietic stem cell niches	P. E. Boulais, P. S. Frenette	Blood	2015	9	8	6
10.1182/blood-2014-09-598029	Dengue virus binding and replication by platelets	A. Y. Simon, M. R. Sutherland, E. L. G. Pryzdial	Blood	2015	14	8	5
10.1182/blood-2015-02-629527	A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies	M. Mamonkin, R. H. Rouce, H. Tashiro, M. K. Brenner	Blood	2015	9	8	7
10.1182/blood-2015-05-635300	Introduction to the review series on acute lymphoblastic leukemia	J. Soulier, J. Cortes	Blood	2015	10	8	3
10.1182/asheducation-2014.1.113	Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis	D. Rossi	Hematology / the Education Program of the American Society of Hematology	2014	7	7	5
10.1182/asheducation-2014.1.174	The genomic landscape of acute lymphoblastic leukemia in children and young adults	C. G. Mullighan	Hematology / the Education Program of the American Society of Hematology	2014	8	7	7
10.1182/asheducation-2014.1.255	Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?	P. G. Richardson, J. P. Laubach, N. C. Munshi, K. C. Anderson	Hematology / the Education Program of the American Society of Hematology	2014	7	7	6
10.1182/asheducation-2014.1.287	The evolving genomic landscape of myeloproliferative neoplasms	J. Nangalia, T. R. Green	Hematology / the Education Program of the American Society of Hematology	2014	7	7	7
10.1182/asheducation-2014.1.481	Optimal disease surveillance strategies in non-Hodgkin lymphoma	J. B. Cohen, C. R. Flowers	Hematology / the Education Program of the American Society of Hematology	2014	7	7	5
10.1182/asheducation-2014.1.518	Reversing targeted oral anticoagulants	M. Hoffman, D. M. Monroe	Hematology / the Education Program of the American Society of Hematology	2014	8	7	6
10.1182/asheducation-2014.1.576	Screening for and management of hepatitis B virus reactivation in patients treated with anti-B-cell therapy	S. Kusumoto, K. Tobinai	Hematology / the Education Program of the American Society of Hematology	2014	8	7	5
10.1182/blood-2013-09-529537	Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells	S. Gill, S. K. Tasian, M. Ruella, O. Shestova, Y. Li, D. L. Porter, M. Carroll, G. Danet-Desnoyers, J. Scholler, S. A. Grupp, C. H. June, M. Kalos	Blood	2014	7	7	5
10.1182/blood-2014-03-562694	Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2	T. Ueda, A. Nagamachi, K. Takubo, N. Yamasaki, H. Matsui, A. Kanai, Y. Nakata, K. Ikeda, T. Konuma, H. Oda, L. Wolff, Z.-i. Honda, X. Wu, K. Helin, A. Iwama, T. Suda, T. Inaba, H. Honda	Blood	2015	7	7	5
10.1182/blood-2014-09-599159	CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease	A. de Masson, J.-D. Bouaziz, H. Le Buanec, M. Robin, A. O'Meara, N. Parquet, M. Rybojad, E. Hau, J.-B. Monfort, M. Branchtein, D. Michonneau, V. Dessirier, F. Sicre de Fontbrune, A. Bergeron, R. Itzykson, N. Dhedin, D. Bengoufa, R. Peffault de Latour, A. Xhaard, M. Bagot, A. Bensussan, G. Socie	Blood	2015	9	7	4
10.1182/blood-2014-11-551580	How I treat refractory thrombotic thrombocytopenic purpura	F. A. Sayani, C. S. Abrams	Blood	2015	7	7	4
10.1182/blood-2014-11-612903	Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein	H. Qin, M. Cho, W. Haso, L. Zhang, S. K. Tasian, H. Z. Oo, G. L. Negri, Y. Lin, J. Zou, B. S. Mallon, S. Maude, D. T. Teachey, D. M. Barrett, R. J. Orentas, M. Daugaard, P. H. B. Sorensen, S. A. Grupp, T. J. Fry	Blood	2015	7	7	6
10.1182/blood-2015-02-567453	Immune checkpoint blockade in hematologic malignancies	P. Armand	Blood	2015	7	7	6
10.1182/asheducation-2014.1.250	All transplantation-eligible patients with myeloma should receive ASCT in first response	P. Moreau, M. Attal	Hematology / the Education Program of the American Society of Hematology	2014	6	6	3
10.1182/asheducation-2014.1.321	Laboratory methods to detect antiphospholipid antibodies	S. A. Krilis, B. Giannakopoulos	Hematology / the Education Program of the American Society of Hematology	2014	6	6	3
10.1182/asheducation-2014.1.559	Chimeric antigen receptor T-cell therapy for ALL	S. L. Maude, E. J. Shpall, S. A. Grupp	Hematology / the Education Program of the American Society of Hematology	2014	6	6	4
10.1182/asheducation-2014.1.8	Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia	H. D. Klepin	Hematology / the Education Program of the American Society of Hematology	2014	6	6	3
10.1182/blood-2014-07-587139	Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models	B. Pickens, Y. Mao, D. Li, D. L. Siegel, M. Poncz, D. B. Cines, X. L. Zheng	Blood	2015	6	6	6
10.1182/blood-2014-09-551937	How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia	N. V. Frey, S. M. Luger	Blood	2015	6	6	5
10.1182/blood-2014-10-605808	Secondary mutations as mediators of resistance to targeted therapy in leukemia	N. Daver, J. Cortes, F. Ravandi, K. P. Patel, J. A. Burger, M. Konopleva, H. Kantarjian	Blood	2015	6	6	6
10.1182/asheducation-2014.1.119	Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1, SF3B1, and TP53	C. S. Zent, W. R. Burack	Hematology / the Education Program of the American Society of Hematology	2014	8	5	3
10.1182/asheducation-2014.1.210	Guidelines for quantifying iron overload	J. C. Wood	Hematology / the Education Program of the American Society of Hematology	2014	5	5	4
10.1182/asheducation-2014.1.244	Detection and management of minimal residual disease in acute lymphoblastic leukemia	M. Schrappe	Hematology / the Education Program of the American Society of Hematology	2014	5	5	4
10.1182/asheducation-2014.1.312	Prevention and treatment of venous thromboembolism in patients with cancer	A. Y. Y. Lee	Hematology / the Education Program of the American Society of Hematology	2014	6	5	5
10.1182/asheducation-2014.1.343	Pharmacogenomics of antiplatelet drugs	M. S. Sabatine, J. L. Mega	Hematology / the Education Program of the American Society of Hematology	2014	5	5	4
10.1182/asheducation-2014.1.444	Thrombotic microangiopathy and indications for therapeutic plasma exchange	J. Adamski	Hematology / the Education Program of the American Society of Hematology	2014	8	5	4
10.1182/asheducation-2014.1.450	Red cell exchange: special focus on sickle cell disease	H. C. Kim	Hematology / the Education Program of the American Society of Hematology	2014	5	5	3
10.1182/asheducation-2014.1.542	The science behind the hypoxic niche of hematopoietic stem and progenitors	C. Nombela-Arrieta, L. E. Silberstein	Hematology / the Education Program of the American Society of Hematology	2014	7	5	2
10.1182/asheducation-2014.1.584	HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options	A. Krishnan, J. A. Zaia	Hematology / the Education Program of the American Society of Hematology	2014	7	5	4
10.1182/blood-2013-11-536433	Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue	D. W. Scott, G. W. Wright, P. M. Williams, C.-J. Lih, W. Walsh, E. S. Jaffe, A. Rosenwald, E. Campo, W. C. Chan, J. M. Connors, E. B. Smeland, A. Mottok, R. M. Braziel, G. Ott, J. Delabie, R. R. Tubbs, J. R. Cook, D. D. Weisenburger, T. C. Greiner, B. J. Glinsmann-Gibson, K. Fu, L. M. Staudt, R. D. Gascoyne, L. M. Rimsza	Blood	2014	13	5	3
10.1182/blood-2014-04-572255	Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation	A. Reinisch, N. Etchart, D. Thomas, N. A. Hofmann, M. Fruehwirth, S. Sinha, C. K. Chan, K. Senarath-Yapa, E.-Y. Seo, T. Wearda, U. F. Hartwig, C. Beham-Schmid, S. Trajanoski, Q. Lin, W. Wagner, C. Dullin, F. Alves, M. Andreeff, I. L. Weissman, M. T. Longaker, K. Schallmoser, R. Majeti, D. Strunk	Blood	2014	6	5	4
10.1182/blood-2014-06-528406	von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends	P. J. Lenting, O. D. Christophe, C. V. Denis	Blood	2015	5	5	4
10.1182/blood-2014-08-570226	Regulatory network control of blood stem cells	B. Gottgens	Blood	2015	5	5	5
10.1182/blood-2014-09-598805	Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury	Y. Tian, B. Salsbery, M. Wang, H. Yuan, J. Yang, Z. Zhao, X. Wu, Y. Zhang, B. A. Konkle, P. Thiagarajan, M. Li, J. Zhang, J.-f. Dong	Blood	2015	6	5	2
10.1182/blood-2014-10-603951	Altered lymphopoiesis and immunodeficiency in miR-142 null mice	N. J. Kramer, W.-L. Wang, E. Y. Reyes, B. Kumar, C.-C. Chen, C. Ramakrishna, E. M. Cantin, S. L. Vonderfecht, K. D. Taganov, N. Chau, M. P. Boldin	Blood	2015	6	5	3
10.1182/blood-2014-10-609370	Leukemia stem cells in T-ALL require active Hif1Â  and Wnt signaling	V. Giambra, C. E. Jenkins, S. H. Lam, C. Hoofd, M. Belmonte, X. Wang, S. Gusscott, D. Gracias, A. P. Weng	Blood	2015	5	5	5
10.1182/blood-2015-02-629543	The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma	T. E. Witzig, C. Reeder, J. J. Han, B. LaPlant, M. Stenson, H. W. Tun, W. Macon, S. M. Ansell, T. M. Habermann, D. J. Inwards, I. N. Micallef, P. B. Johnston, L. F. Porrata, J. P. Colgan, S. Markovic, G. S. Nowakowski, M. Gupta	Blood	2015	5	5	3
10.1182/asheducation-2014.1.100	Impact of MYC on malignant behavior	G. Ott	Hematology / the Education Program of the American Society of Hematology	2014	4	4	4
10.1182/asheducation-2014.1.135	The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease	A. M. Evens, L. Kostakoglu	Hematology / the Education Program of the American Society of Hematology	2014	4	4	4
10.1182/asheducation-2014.1.21	Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults	M. L. Sorror, E. Estey	Hematology / the Education Program of the American Society of Hematology	2014	4	4	2
10.1182/asheducation-2014.1.222	"Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for ""prime time""?"	D. Grimwade, S. D. Freeman	Hematology / the Education Program of the American Society of Hematology	2014	35	4	3
10.1182/asheducation-2014.1.234	Goals for chronic myeloid leukemia TK inhibitor treatment: how little disease is too much?	M. J. Mauro	Hematology / the Education Program of the American Society of Hematology	2014	4	4	4
10.1182/asheducation-2014.1.240	Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors	D. T. Yeung, M. J. Mauro	Hematology / the Education Program of the American Society of Hematology	2014	4	4	3
10.1182/asheducation-2014.1.262	A practical approach to relapsed multiple myeloma	J. R. Mikhael	Hematology / the Education Program of the American Society of Hematology	2014	4	4	4
10.1182/asheducation-2014.1.268	How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?	E. Chen, A. Mullally	Hematology / the Education Program of the American Society of Hematology	2014	6	4	4
10.1182/asheducation-2014.1.34	Intermediate-risk acute myeloid leukemia therapy: current and future	K. Dohner, P. Paschka	Hematology / the Education Program of the American Society of Hematology	2014	5	4	4
10.1182/asheducation-2014.1.364	Toward optimal therapy for inhibitors in hemophilia	C. L. Kempton, S. L. Meeks	Hematology / the Education Program of the American Society of Hematology	2014	4	4	4
10.1182/asheducation-2014.1.379	Anticoagulation and in vitro fertilization and ovarian stimulation	S. M. Bates	Hematology / the Education Program of the American Society of Hematology	2014	4	4	3
10.1182/asheducation-2014.1.488	Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects	A. K. Ng	Hematology / the Education Program of the American Society of Hematology	2014	4	4	4
10.1182/asheducation-2014.1.504	Bleeding complications of targeted oral anticoagulants: what is the risk?	M. Levine, J. N. Goldstein	Hematology / the Education Program of the American Society of Hematology	2014	4	4	3
10.1182/asheducation-2014.1.514	What is the role of hemodialysis for dabigatran-associated major bleeding?	B. Kim, D. A. Garcia	Hematology / the Education Program of the American Society of Hematology	2014	4	4	2
10.1182/asheducation-2014.1.52	Future prospects for contact factors as therapeutic targets	D. Gailani	Hematology / the Education Program of the American Society of Hematology	2014	4	4	4
10.1182/asheducation-2014.1.524	Clinical and laboratory diagnosis of VWD	A. B. Federici	Hematology / the Education Program of the American Society of Hematology	2014	4	4	3
10.1182/asheducation-2014.1.553	Bloodless medicine: what to do when you can't transfuse	L. M. S. Resar, S. M. Frank	Hematology / the Education Program of the American Society of Hematology	2014	4	4	4
10.1182/blood-2014-02-554634	Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis	R. Rampal, F. Al-Shahrour, O. Abdel-Wahab, J. P. Patel, J.-P. Brunel, C. H. Mermel, A. J. Bass, J. Pretz, J. Ahn, T. Hricik, O. Kilpivaara, M. Wadleigh, L. Busque, D. G. Gilliland, T. R. Golub, B. L. Ebert, R. L. Levine	Blood	2014	4	4	2
10.1182/blood-2014-04-526293	Stress and DNA repair biology of the Fanconi anemia pathway	S. Longerich, J. Li, Y. Xiong, P. Sung, G. M. Kupfer	Blood	2014	4	4	4
10.1182/blood-2014-04-568949	Maintenance of mouse hematopoietic stem cells ex vivo by reprogramming cellular metabolism	X. Liu, H. Zheng, W.-M. Yu, T. M. Cooper, K. D. Bunting, C.-K. Qu	Blood	2015	4	4	2
10.1182/blood-2014-06-580993	Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia	C. H. Man, T. K. Fung, H. Wan, C. Y. Cher, A. Fan, N. Ng, C. Ho, T. S. K. Wan, T. Tanaka, C. W. E. So, Y. L. Kwong, A. Y. H. Leung	Blood	2015	7	4	2
10.1182/blood-2014-08-596775	HIV-1 reprograms the migration of macrophages	C. Verollet, S. Souriant, E. Bonnaud, P. Jolicoeur, B. Raynaud-Messina, C. Kinnaer, I. Fourquaux, A. Imle, S. Benichou, O. T. Fackler, R. Poincloux, I. Maridonneau-Parini	Blood	2014	4	4	4
10.1182/blood-2014-09-568899	Smoldering multiple myeloma	S. V. Rajkumar, O. Landgren, M.-V. Mateos	Blood	2015	4	4	4
10.1182/blood-2014-10-551895	How I treat T-cell acute lymphoblastic leukemia in adults	M. R. Litzow, A. A. Ferrando	Blood	2015	6	4	3
10.1182/blood-2014-10-567479	The biology and treatment of plasmablastic lymphoma	J. J. Castillo, M. Bibas, R. N. Miranda	Blood	2015	4	4	4
10.1182/blood-2014-11-551481	How I treat acute lymphoblastic leukemia in older adolescents and young adults	E. Curran, W. Stock	Blood	2015	5	4	4
10.1182/blood-2014-11-611459	Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells	M. P. Martelli, I. Gionfriddo, F. Mezzasoma, F. Milano, S. Pierangeli, F. Mulas, R. Pacini, A. Tabarrini, V. Pettirossi, R. Rossi, C. Vetro, L. Brunetti, P. Sportoletti, E. Tiacci, F. Di Raimondo, B. Falini	Blood	2015	5	4	2
10.1182/blood-2014-11-612721	Targeting of folate receptor Â  on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells	R. C. Lynn, M. Poussin, A. Kalota, Y. Feng, P. S. Low, D. S. Dimitrov, D. J. Powell	Blood	2015	4	4	4
10.1182/blood-2014-12-616250	Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea	C. B. Almeida, L. E. B. Souza, F. C. Leonardo, F. T. M. Costa, C. C. Werneck, D. T. Covas, F. F. Costa, N. Conran	Blood	2015	4	4	3
10.1182/blood-2015-01-621631	IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells	C. Schinke, O. Giricz, W. Li, A. Shastri, S. Gordon, L. Barreyro, T. Bhagat, S. Bhattacharyya, N. Ramachandra, M. Bartenstein, A. Pellagatti, J. Boultwood, A. Wickrema, Y. Yu, B. Will, S. Wei, U. Steidl, A. Verma	Blood	2015	4	4	3
10.1182/blood-2015-01-624023	P-selectin promotes neutrophil extracellular trap formation in mice	J. Etulain, K. Martinod, S. L. Wong, S. M. Cifuni, M. Schattner, D. D. Wagner	Blood	2015	5	4	4
10.1182/blood-2015-03-635169	Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing	D. M. Kurtz, M. R. Green, S. V. Bratman, F. Scherer, C. L. Liu, C. A. Kunder, K. Takahashi, C. Glover, C. Keane, S. Kihira, B. Visser, J. Callahan, K. A. Kong, M. Faham, K. S. Corbelli, D. Miklos, R. H. Advani, R. Levy, R. J. Hicks, M. Hertzberg, R. S. Ohgami, M. K. Gandhi, M. Diehn, A. A. Alizadeh	Blood	2015	4	4	3
10.1182/asheducation-2014.1.169	Therapeutic targeting of microenvironment in follicular lymphoma	G. S. Nowakowski, S. M. Ansell	Hematology / the Education Program of the American Society of Hematology	2014	5	3	3
10.1182/asheducation-2014.1.329	Monitoring target-specific oral anticoagulants	B. A. Konkle	Hematology / the Education Program of the American Society of Hematology	2014	3	3	3
10.1182/asheducation-2014.1.387	Pregnancy and venous thromboembolism: 'TIPPS' for risk stratification	M. Rodger	Hematology / the Education Program of the American Society of Hematology	2014	3	3	3
10.1182/asheducation-2014.1.410	Flamethrowers: blood cells and cancer thrombosis risk	I. Pabinger, F. Posch	Hematology / the Education Program of the American Society of Hematology	2014	3	3	3
10.1182/asheducation-2014.1.432	Does hydroxyurea prevent pulmonary complications of sickle cell disease?	T. W. Buckner, K. I. Ataga	Hematology / the Education Program of the American Society of Hematology	2014	3	3	1
10.1182/asheducation-2014.1.457	Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia	N. Aqui, U. O'Doherty	Hematology / the Education Program of the American Society of Hematology	2014	4	3	3
10.1182/asheducation-2014.1.461	Replacing bad (F)actors: hemophilia	C. B. Doering, H. T. Spencer	Hematology / the Education Program of the American Society of Hematology	2014	3	3	3
10.1182/asheducation-2014.1.475	Eliminating SCID row: new approaches to SCID	D. B. Kohn	Hematology / the Education Program of the American Society of Hematology	2014	4	3	2
10.1182/asheducation-2014.1.565	Cytotoxic T lymphocytes for leukemia and lymphoma	C. M. Bollard, A. J. Barrett	Hematology / the Education Program of the American Society of Hematology	2014	4	3	3
10.1182/asheducation-2014.1.66	Epidemiologic and clinical data linking factors XI and XII to thrombosis	N. S. Key	Hematology / the Education Program of the American Society of Hematology	2014	3	3	2
10.1182/asheducation-2014.1.71	Biology of BM failure syndromes: role of microenvironment and niches	S. R. Balderman, L. M. Calvi	Hematology / the Education Program of the American Society of Hematology	2014	4	3	3
